AMD, GE Lead Market Cap Stock Movers on Wednesday
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc stock price live, this page displays NASDAQ STOK stock exchange data. View the STOK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Stoke Therapeutics Inc real time stock price chart below.
What Is the Stoke Therapeutics Inc Stock Price Today?
The Stoke Therapeutics Inc stock price today is 17.17.
What Is the Stock Symbol for Stoke Therapeutics Inc?
The stock symbol for Stoke Therapeutics Inc is ""STOK.""
What Stock Exchange Does Stoke Therapeutics Inc Trade On?
Stoke Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Stoke Therapeutics Inc a Good Stock to Buy?
Determining whether Stoke Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STOK quote. (ISIN: US86150R1077)
What Is the Stoke Therapeutics Inc Stock Price Today?
The Stoke Therapeutics Inc stock price today is 17.17.
What Is the Stock Symbol for Stoke Therapeutics Inc?
The stock symbol for Stoke Therapeutics Inc is ""STOK.""
What Stock Exchange Does Stoke Therapeutics Inc Trade On?
Stoke Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Stoke Therapeutics Inc a Good Stock to Buy?
Determining whether Stoke Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STOK quote. (ISIN: US86150R1077)
Fair Value
An estimate of a Stoke Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.50
17.32
52 wk Range
5.35
17.61
STOK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
1/2
Fair Value
An estimate of a Stoke Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.5017.32
52 wk Range
5.3517.61
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STOK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Stoke Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
23.89
Upside
+39.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Stoke Therapeutics Inc Company Profile
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Stoke Therapeutics Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of -$0.40 beat expectations of -$0.50; revenue of $13.8M surpassed $9.39M forecast
- Strong cash position to fund operations through mid-2028; stock rose 2.81% post-earnings
- Phase III EMPEROR study for Zorivanersen progressing; enrollment completion expected in 2026
- Analyst consensus bullish with price targets $15-$35; company maintains excellent financial health score
- R&D and G&A expenses remain high; lengthy clinical trials and regulatory hurdles pose challenges
Last Updated: 12/08/2025, 22:54
Read Full TranscriptCompare STOK to Peers and Sector
Metrics to compare | STOK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTOKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.9x | −3.6x | −0.5x | |
PEG Ratio | 0.12 | −0.07 | 0.00 | |
Price/Book | 2.8x | 1.9x | 2.6x | |
Price / LTM Sales | 4.7x | 8.1x | 3.3x | |
Upside (Analyst Target) | 31.2% | 151.2% | 40.3% | |
Fair Value Upside | Unlock | 1.5% | 4.7% | Unlock |
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23.89
(+39.13% Upside)
Earnings
Latest Release
Aug 12, 2025
EPS / Forecast
-0.40 / -0.50
Revenue / Forecast
13.82M / 9.39M
People Also Watch
FAQ
What Stock Exchange Does Stoke Therapeutics Trade On?
Stoke Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Stoke Therapeutics?
The stock symbol for Stoke Therapeutics is "STOK."
What Is the Stoke Therapeutics Market Cap?
As of today, Stoke Therapeutics market cap is 943.43M.
What Is Stoke Therapeutics's Earnings Per Share (TTM)?
The Stoke Therapeutics EPS (TTM) is 0.91.
When Is the Next Stoke Therapeutics Earnings Date?
Stoke Therapeutics will release its next earnings report on 10 Nov 2025.
From a Technical Analysis Perspective, Is STOK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Stoke Therapeutics Stock Split?
Stoke Therapeutics has split 0 times.
How Many Employees Does Stoke Therapeutics Have?
Stoke Therapeutics has 128 employees.
What is the current trading status of Stoke Therapeutics (STOK)?
As of 14 Aug 2025, Stoke Therapeutics (STOK) is trading at a price of 17.17, with a previous close of 16.91. The stock has fluctuated within a day range of 15.50 to 17.32, while its 52-week range spans from 5.35 to 17.61.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.